コンテンツへスキップ
Merck
  • VEGF-C-dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel disease.

VEGF-C-dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel disease.

The Journal of clinical investigation (2014-08-12)
Silvia D'Alessio, Carmen Correale, Carlotta Tacconi, Alessandro Gandelli, Giovanni Pietrogrande, Stefania Vetrano, Marco Genua, Vincenzo Arena, Antonino Spinelli, Laurent Peyrin-Biroulet, Claudio Fiocchi, Silvio Danese
要旨

Crohn's disease (CD) and ulcerative colitis (UC) are chronic inflammatory bowel diseases (IBDs) of unknown etiology that are associated with an aberrant mucosal immune response. Neoangiogenesis and vascular injury are observed in IBD along with increased lymphangiogenesis. While the pathogenic role of angiogenesis in IBD is well characterized, it is not clear how or if increased lymphangiogenesis promotes disease. Here, we determined that enhancing lymphangiogenesis and lymphatic function reduces experimental IBD. Specifically, we demonstrated that adenoviral induction of prolymphangiogenic factor VEGF-C provides marked protection against the development of acute and chronic colitis in 2 different animal models. VEGF-C-dependent protection was observed in combination with increased inflammatory cell mobilization and bacterial antigen clearance from the inflamed colon to the draining lymph nodes. Moreover, we found that the VEGF-C/VEGFR3 pathway regulates macrophage (MΦ) plasticity and activation both in cultured MΦs and in vivo, imparting a hybrid M1-M2 phenotype. The protective function of VEGF-C was meditated by the so-called resolving MΦs during chronic experimental colitis in a STAT6-dependent manner. Together, these findings shed light on the contribution of lymphatics to the pathogenesis of gut inflammation and suggest that correction of defective lymphatic function with VEGF-C has potential as a therapeutic strategy for IBD.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
ホルムアミド, ReagentPlus®, ≥99.0% (GC)
Sigma-Aldrich
DAPI, for nucleic acid staining
Sigma-Aldrich
ホルムアルデヒド 溶液, for molecular biology, 36.5-38% in H2O
SAFC
ホルムアルデヒド 溶液, contains 10-15% methanol as stabilizer, 37 wt. % in H2O
Sigma-Aldrich
ホルムアミド, BioReagent, ≥99.5% (GC), for molecular biology
Sigma-Aldrich
ホルムアミド, BioUltra, for molecular biology, ≥99.5% (T)
Sigma-Aldrich
アジ化ナトリウム, BioUltra, ≥99.5% (T)
Sigma-Aldrich
ホルムアルデヒド 溶液, for molecular biology, BioReagent, ≥36.0% in H2O (T)
Sigma-Aldrich
アジ化ナトリウム, purum p.a., ≥99.0% (T)
Sigma-Aldrich
ヘマトキシリン
Supelco
ホルムアルデヒド 溶液, stabilized with methanol, ~37 wt. % in H2O, certified reference material
Sigma-Aldrich
アジ化ナトリウム, ReagentPlus®, ≥99.5%
Sigma-Aldrich
ホルムアルデヒド 溶液, ACS reagent, 37 wt. % in H2O, contains 10-15% Methanol as stabilizer (to prevent polymerization)
Sigma-Aldrich
ホルムアミド, spectrophotometric grade, ≥99%
Sigma-Aldrich
ホルムアルデヒド 溶液, meets analytical specification of USP, ≥34.5 wt. %
Sigma-Aldrich
ホルムアミド, puriss. p.a., ACS reagent, ≥99.5% (GC/T)
Sigma-Aldrich
アジ化ナトリウム, BioXtra
Sigma-Aldrich
ヘマトキシリン, certified by the Biological Stain Commission
Sigma-Aldrich
ホルムアルデヒド 溶液, tested according to Ph. Eur.
Sigma-Aldrich
ホルムアルデヒド 溶液, SAJ first grade, ≥35.0%, contains methanol as stabilizer
Sigma-Aldrich
ホルムアルデヒド 溶液, 10%
Sigma-Aldrich
ホルムアルデヒド 溶液, JIS special grade, 36.0-38.0%, contains methanol as stabilizer
Sigma-Aldrich
Formaldehyde-12C solution, 20% in H2O, 99.9 atom % 12C
Sigma-Aldrich
ホルムアミド, JIS special grade, ≥98.5%
Sigma-Aldrich
ホルムアミド, ACS reagent, ≥99.5%
Supelco
ホルムアミド 溶液, NMR reference standard, 90% in DMSO-d6 (99.9 atom % D), NMR tube size 5 mm × 8 in.
Sigma-Aldrich
ホルムアミド, SAJ first grade, ≥98.5%
Sigma-Aldrich
ホルムアミド, puriss. p.a., ACS reagent, ≥99.5% (GC/T)
Supelco
ホルムアミド 溶液, NMR reference standard, 90% in DMSO-d6 (99.9 atom % D), NMR tube size 5 mm × 8 in.